CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,602 followers.

CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway https://t.co/wqEq33kX0g

15 Sep 2022

Reply Repost Favourite

📣 Original Research Article: #CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in #colorectalcancer through inhibiting the mitochondrial #apoptosis pathway 👨‍⚕️👩‍⚕️ Xie C et al Read here 👉 https://t.co/0SHgM

06 Sep 2022

Reply Repost Favourite

New research: CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway: The first-line anticancer agent oxaliplatin (OXL) is the… https://t.co

30 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.